Reference change · event page

Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

Published notice on a work cited in the Pith corpus. Exact quotes below. No model judges whether any citation was load-bearing.

This page records that a citing paper's bibliography includes a work with a published notice. It is not a judgment on the citing paper.

Correction Crossref 1 open · 1 total · 0 disputed

DOI: 10.1038/s41591-020-0840-5
Notice DOI: 10.1038/s41591-020-0973-6
Event date: 2020-06-18
Machine twin: JSON

01One-hop citing occurrences

Correction Open

Artificial Intelligence for CRISPR Guide RNA Design: Explainable Models and Off-Target Safety

ref [29] · 2508.20130 · notice #8533 · dispute

Raw extraction · bibliography line

Lu, Y., Xue, J., Deng, T., Zhou, X., Yu, K., Deng, L., Huang, M., Yi, X., Liang, M., Wang, Y., Shen, H., Tong, R., Wang, W., Li, L., Song, J., Li, J., Su, X., Ding, Z., Gong, Y., Zhu, J., Wang, Y., Zou, B., Zhang, Y., Li, Y., Zhou, L., Liu, Y., Yu, M., Wang, Y., Zhang, X., Yin, L., Xia, X., Zeng, Y., Zhou, Q., Ying, B., Chen, C., Wei, Y., Li, W., Mok, T.: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. Nat. Med. 26(5), 732–740 (2020). DOI 10.1038/s41591-020-0840-5

Status lifecycle on notices: open → disputed → (response attached on the notice page). Repaired counts matter as much as open counts. There is no “safe,” “invalid,” or “resolved” badge.